Calcium glutarate supplement and phosphorus binder

   
   

Methods of controlling calcium intake and phosphate metabolism and metabolic acidosis in patients suffering from renal failure and associated hyperphosphatemia or patients predisposed to development of a hyperphosphatemic condition are provided. The method in accordance with this invention comprises administering to a patient a calcium glutarate compound. Therapeutic benefit can be realized in accordance with such method by administering the compound orally to a patient to increase available calcium and contact and bind with ingested phosphate in the patient's digestive tract, and thereby prevent its intestinal absorption.

 
Web www.patentalert.com

< Nucleic acids encoding modified parathyroid hormone

< Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith

> Compounds that modulate PPAR activity and methods for their preparation

> Methods and compositions for modulating ACE-2 activity

~ 00178